NR3C2 and hydrops fetalis: Management of HF includes both lifestyle modification and pharmacological, majority of patients regardless of symptom severity, require lifelong optimal medical treatment which includes angiotensin-converting enzyme inhibitors (ACEIs), beta-blocker (BB), and mineralocorticoid receptor antagonists (MRA) that decrease hospitalization and mortality [2, 7, 8].